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Functional neuroimaging as a direct probe 
of the effects of gonadal steroid hormones 
on the brain 
Measurable parameters of brain function
No single parameter completely,or even best,describes
the functional status of the brain.Any measurement of
brain “activity” subsumes a complex set of biochemical
and physiological phenomena subserving diverse neu-
ronal activities, such as cellular homeostasis, neuronal
excitation and inhibition, maintenance of membrane
potentials,and plastic change at the cellular or subcellu-
lar level.The choice of which parameter to measure in a
given study must be guided by the particular research
question, and the use of multiple imaging methods to
obtain information about several different parameters in
the same patients is perhaps the most informative
approach (Figure 1).
Measures of general neuronal activity
The idea of measuring regional cerebral blood flow
(rCBF, with positron emission tomography [PET] and
IV H2
15O or inhaled 
15O2 or C
15O) or blood oxygenation
level (with functional magnetic resonace imaging
[fMRI]) to assess neural activity is well grounded in a
firm theoretical base beginning with observations in the
late 1800s that an augmented level of tissue function is
sustained by increasing the rate of oxygen consumption
and, therefore, the flow of oxygenated blood to the tis-
sue (in this case, brain). Because these parameters can
be measured in less than a minute and repeatedly, they
are well suited to delineating the cerebral concomitants
of transient mental phenomena such as cognition and
emotion.
The brain’s energy requirements, among the highest of
any organ system, are normally provided by blood glu-
cose.The PET [
18F]fluorodeoxyglucose (FDG) technique
for measuring local cerebral metabolic rate of glucose
(CMRGlu) is based on the fact that deoxyglucose and
glucose are transported across the blood–brain barrier
by the same carrier,but in cerebral tissues they are phos-
phorylated to deoxyglucose-6-phosphate and glucose-
6-phosphate,respectively,which have differing fates.The
latter is metabolized to CO2 and water,while the former
is “trapped” in neurons long enough to be imaged, if
radiolabeled. The long measurement period of this
method (a 20- to 30-min scan carried out 30 to 40 min
postinjection,when CMRGlu is assumed to have reached
a steady state) limits its temporal resolution and sensi-
tivity to cognitive and acute pharmacological activations;
it is, therefore, best suited to providing detailed, quanti-
tative maps of trait-like brain functional characteristics,as
opposed to mental states.
Measurement of neurochemical systems 
Using PET to image and quantify the functional activity
of various neurochemical system components (eg,neuro-
There is considerable evidence from animal studies that gonadal steroid hormones modulate
neuronal activity and affect behavior. In humans, however, the behavioral and cognitive evidence
has not been conclusive, and, until recently, there have been few direct neurophysiological data.
Functional brain imaging offers unique opportunities to characterize in humans the effects of
gonadal steroid hormones on basic neurobiological parameters, such as neuronal metabolism
and neurochemical systems, and to clarify the interactions between these hormones and 
cognition and mood regulation in health and disease.The most commonly used tools within the
considerable armamentarium available for such research and the parameters of neural function
that they can access are briefly reviewed here.193
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receptors and enzymes) has much in common with
autoradiography and in vitro receptor-binding tech-
niques. A specific ligand (or binding agent) is labeled
with a positron emitter and injected into the subject and
the anatomical distribution of the radioligand in the
brain is determined with PET.A quantitative estimate of
specific receptor binding can be achieved by compart-
mental modeling to account for the kinetic behavior of
the ligand between extra- and intracerebral plasma and
tissue,as well as nonspecific binding and extraneuronal
concentration.Alternatively,and more simply,the radi-
oligand concentration in a brain area known to have lit-
tle or no specific binding (eg, the cerebellum for
dopamine receptors) can be used to estimate nonspe-
cific binding. PET ligands are available for dopamine,
opiate, serotonin, benzodiazepine, and other receptors.
Cerebral concentration and distribution of neurotrans-
mitter turnover and enzymes can also be measured using
ligands, such as [
11C]clorgiline and L-[
11C]deprenyl,
irreversible inhibitors of monoamine oxidase (MAO)
for mapping MAOA and MAOB, respectively, and 
[
18F]dihyroxyphenylalanine ([
18F]DOPA), an analog of
the dopamine precursor. Distribution and kinetics of
pharmacological agents such as [
11C]chlorpromazine,
[
11C]benztropine, and [
11C]cocaine can also be deter-
mined. Ligands specific to gonadal steroid hormones
that cross the blood–brain barrier have yet to be devel-
oped.
Magnetic resonance spectroscopy (MRS) is a chemical
assay technique for measuring chemical moieties in the
living brain.
31P spectroscopy measures high energy com-
pounds and phospholipids (eg,phosphomonoesters and
phosphodiesters, ATP, phosphocreatine), which reflect
the energy state of neurons and constituents such as
membrane precursors.
1H spectroscopy can detect amino
acids, energy substrates, and membrane and myelin
metabolites.Its greatest application has been to measure
N-acetyl aspartate,an intracellular neuronal marker and
sensitive indicator of neuronal pathology.
Available methods for functional 
brain imaging
Positron emission tomography
PET involves the administration of cyclotron-produced
radioisotopes such as 
18F,
15O, and 
11C.These atoms emit
very short-lived positrons that are rapidly annihilated,
producing two characteristic photons of equal energy
that can be simultaneously detected by a ring of crystals
outside the head. PET’s spatial resolution is 3 to 6 mm,
and it is sensitive enough for sequential scans of very
short duration (eg, 5 to 20 s) to be acquired, providing
detailed information about the kinetic behavior of the
radiotracer. This has been particularly important in
studying neuroreceptors,and allows rapid measurement
Figure 1. Positron emission tomography (PET)
images in the same patient made with
[
18F]dihydroxyphenylalanine (F-DOPA)
(left) showing high presynaptic con-
centrations primarily in the basal gan-
glia and H2
15O (right) showing high
regional cerebral blood flow (rCBF) in
cortical and subcortical gray matter
structures.
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of the very short-lived 
15O blood flow agents (eg, total
scanning time of 40 s for H2
15O). The major disadvan-
tage of PET lies in its invasiveness and expense,and in
the limitations of short-lived radiotracers. For fully
quantitative studies,radial arterial lines are necessary to
continuously monitor the amount of radioisotope being
delivered to the brain by the arterial blood supply.How-
ever, for paired studies, in which one is mainly inter-
ested in the difference between the two data sets or
their relative values, adequate information can be
obtained by simply comparing the regional count rates
between the two (Figure 2), obviating the need for the
arterial catheter.
Magnetic resonance imaging
MRI is based on the behavior of atoms with unpaired
protons in a magnetic field. Most commonly, the signal
from 
1H, most abundant in water and lipids, is used to
construct images.During the last decade,the traditional
use of MRI for anatomical imaging expanded to probe
biochemistry and blood flow through two major
advances,spectroscopy and ultrafast imaging.The latter
takes advantage of the different magnetic properties of
oxyhemoglobin and deoxyhemoglobin to rapidly mea-
sure blood oxygenation in the brain (the blood oxy-
gen–level dependent [BOLD] method).Because of the
improved temporal and spatial resolution of this tech-
nique, and because it has no radiation exposure (and,
thus, the potential for unlimited repeated scans on a
single individual under different cognitive, pharmaco-
logical,or hormonal states),it is now the premier imag-
ing tool for research on cognitive neuroscience and clin-
ical neuropsychiatry. MRS detects and resolves the
smaller signals from other elements such as 
31P and 
23Na.
Like nuclear magnetic resonance (NMR) spectroscopy,
the unique chemical shifts in the spectra of various mol-
ecules provide the signal used to create images.
An application: gonadal steroid hormones
and brain function
To directly study the effects of the gonadal steroid hor-
mones estrogen and progesterone on brain function in
humans, we used an incisive hormonal manipulation
protocol based on ovarian suppression induced by the
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Figure 2. Top: Unprocessed regional
cerebral blood flow (rCBF)
scans in a single individual
during right finger movement
and rest, and the activation
pattern resulting from sub-
traction of the rest from the
motor scans, highlighting the
primary motor cortex (arrows).
Bottom: Statistically signifi-
cant area of activation (color-
coded z scores) mapped onto
a magnetic resonance imag-
ing (MRI) slice (left) and later-
al view of the brain (right).
Dashed line shows level of
slices.195
gonadotropin-releasing hormone agonist leuprolide
acetate (Lupron) with H2
15O PET to measure rCBF in
young women during three pharmacologically controlled
hormonal conditions spanning 4 to 5 months:
(i) ovarian suppression induced by leuprolide acetate;
(ii) leuprolide acetate plus estradiol replacement; and
(iii) leuprolide acetate plus progesterone replacement.
Estradiol and progesterone were administered sepa-
rately and in a double-blind,crossover design.We found
that when the endogenous ovarian hormones, estrogen
and progesterone,of young women were pharmacolog-
ically ablated, the neurophysiological response to per-
forming a frontal lobe task (the Wisconsin Card Sort-
ing Test [WCS]) was attenuated, and the typically seen
frontal lobe activation virtually disappeared. When
either estrogen or progesterone was pharmacologically
“added back”to the hypogonadism produced by leupro-
lide acetate, the activation pattern in response to the
cognitive challenge of the WCS normalized and the pre-
frontal activation was reestablished (Figure 3). These
data directly demonstrate that gonadal steroid hor-
mones affect cognitively related neural activity. They
also illustrate how functional neuroimaging can provide
a framework for understanding the neurobiological
mechanisms underlying gender-related brain features
as well as hormone-related neuropsychiatric and neu-
ropsychological disorders.❏
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Figure 3. Regional cerebral blood flow (rCBF) group average activation maps for 11 women during three differ-
ent hormonal states. Top: Activation (red voxels) during the Wisconsin Card Sorting (WCS) test; the arrow
shows that the characteristic prefrontal activation typically seen with this task was abolished during leupro-
lide acetate alone (ie, in the absence of estrogen and progesterone) and was reestablished when estro-
gen or progesterone was replaced. Bottom: In contrast, primary visual and motor activation in the same
women during the same scanning sessions, was unaltered, demonstrating that the finding in the pre-
frontal cortex was not due to purely vascular effects and that it was associated relatively specifically to the
cognitive system accessed by the WCS.
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